Skip navigation

Search results for the

Showing 46 to 60 of 2557 results

Education

We approve and monitor programmes within the UK for the professions we regulate

Partner roles

There are a wide range of different partner roles that provide the expertise we need for our decision making processes.

Employer hub

Everything you need to support your employees, whether you’re looking for information on the registration process or events to connect with us

Period of adaptation (POA)

A period of supervised practice intended to make up for significant shortfalls in an international application.

Closure of the COVID-19 Temporary Register

The COVID-19 Temporary Register will close on the 31 March 2024.

Practising outside the UK

What to do if you're planning on practising abroad

Managing concerns about an employee

As an employer or manager, you will manage any concerns about your employees’ performance or behaviour

Top tips for professionalism on social media during COVID-19

Katherine Timms, Head of Policy and Standards, provides advice on how professionals can use social media appropriately during COVID-19

Failure to provide adequate care

Case study: A professional body raised a concern that a biomedical scientist had acted beyond her scope of practise.

Bringing profession into disrepute / inappropriate comments on social media

Case study: A paramedic self-referred after he posted inappropriate comments on social media, which caused his employer to suspend him.

Student hub

This hub provides guidance and learning materials for students and learners.

Launch date announced for specialist social work regulator

Nadhim Zahawi has announced Monday 2 December 2019 as the date when Social Work England will take over from the HCPC as the new social work regulator

Social Work England

Important information for social workers in England regarding the transfer of regulation to Social Work England including FAQs

How we’re supporting you with the updates to our standards of proficiency

Adam Haxell, Strategic Relationships Lead, sets out the activities in this key period of engagement, to raise awareness of our updated standards and help registrants overcome any barriers they may face in meeting them.

Reclassification of gabapentin and pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)